ESCAP 2025 Sponsors
Gold Partner +

Silver Partner
Bronze Partner
ABOUT NEURIM PHARMACEUTICALS
Neurim Pharmaceuticals Ltd. (www.neurim.com) is a neuroscience pharma company, focusing on discovering and developing innovative drugs for CNS diseases.
In response to the unmet medical need in the field of pediatric insomnia, Neurim developed Slenyto® – an innovative age-appropriate formulation, indicated for the treatment of insomnia in children and adolescents aged 2-18 with ASD and/or neurogenetic disorders. For more information, please visit www.slenyto.com